Cvs Pharmacy # 10950 | |
1473 Kentucky St, Bowling Green, Kentucky 42101 | |
(270) 783-8551 |
Name | Cvs Pharmacy # 10950 |
---|---|
Organization Name | Kentucky Cvs Pharmacy Llc |
Location | 1473 Kentucky St, Bowling Green, Kentucky 42101 |
Type | Supplier |
Phone | (270) 783-8551 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Breast cancer rates among African American women in the United States have continued to increase, converging with rates among white women and closing a gap that had existed for decades. The finding is part of Breast Cancer Statistics, 2015, published in CA: A Cancer Journal for Clinicians, and its accompanying consumer publication, Breast Cancer Facts & Figures.
A team of French scientists have found the dose of DHA (docosahexaenoic acid) that is "just right" for preventing cardiovascular disease in healthy men. In a research report appearing in the September 2009 print issue of The FASEB Journal, the scientists show that a 200 mg dose of DHA per day is enough to affect biochemical markers that reliably predict cardiovascular problems, such as those related to aging, atherosclerosis, and diabetes. This study is the first to identify how much DHA is necessary to promote optimal heart health.
The American Society of Anesthesiologists (ASA) today released results from the inaugural Vital Health Report, which demonstrate that Americans associate good health with lifestyle behaviors and habits, but overlook their key Vital Health measures (e.g. cholesterol, body mass index, blood pressure, disease screenings), some of the true indicators of overall health. The report further reveals that Americans believe they know more about their Vital Health than they actually do.
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.
Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise. Normally, cells - even early-stage tumor cells - are tethered to scaffolding that helps to restrain any destructive tendencies. But scientists from the University of Helsinki, Finland, and from UCSF have identified a cleaver-wielding protein that frees some tumor cells, allowing them to further misbehave.
› Verified 9 days ago
News Archive
Breast cancer rates among African American women in the United States have continued to increase, converging with rates among white women and closing a gap that had existed for decades. The finding is part of Breast Cancer Statistics, 2015, published in CA: A Cancer Journal for Clinicians, and its accompanying consumer publication, Breast Cancer Facts & Figures.
A team of French scientists have found the dose of DHA (docosahexaenoic acid) that is "just right" for preventing cardiovascular disease in healthy men. In a research report appearing in the September 2009 print issue of The FASEB Journal, the scientists show that a 200 mg dose of DHA per day is enough to affect biochemical markers that reliably predict cardiovascular problems, such as those related to aging, atherosclerosis, and diabetes. This study is the first to identify how much DHA is necessary to promote optimal heart health.
The American Society of Anesthesiologists (ASA) today released results from the inaugural Vital Health Report, which demonstrate that Americans associate good health with lifestyle behaviors and habits, but overlook their key Vital Health measures (e.g. cholesterol, body mass index, blood pressure, disease screenings), some of the true indicators of overall health. The report further reveals that Americans believe they know more about their Vital Health than they actually do.
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.
Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise. Normally, cells - even early-stage tumor cells - are tethered to scaffolding that helps to restrain any destructive tendencies. But scientists from the University of Helsinki, Finland, and from UCSF have identified a cleaver-wielding protein that frees some tumor cells, allowing them to further misbehave.
› Verified 9 days ago
Medequip Type: Durable Medical Equipment & Medical Supplies Supplier Location: 825 2nd Ave East, Bowling Green, Kentucky 42101 Phone: (270) 780-2655 | |
Tomorrow's Woman Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1623 Scottsville Rd, Bowling Green, Kentucky 42104 Phone: (270) 781-5171 | |
Vision Source Of Bowling Green Type: Medicare Supplier Location: 335 New Towne Rd, Bowling Green, Kentucky 42103 Phone: (270) 842-0383 | |
C.d.s. #10 Pharmacy Llc Type: Long Term Care Pharmacy Location: 1308 Ashley Circle, Bowling Green, Kentucky 42104 Phone: (270) 781-5661 | |
Springhill Pharmacy Type: Pharmacy Location: 2305 Russellville Rd, Bowling Green, Kentucky 42101 Phone: (270) 796-3909 |